This study is a prospective, multicentre, parallel-group, active-controlled, non-inferiority study conducted in adult patients with moderate-to-severe dry eye disease (DED) related to keratitis or keratoconjunctivitis. This study is conducted at a national level, in France.
The patients will be randomised to receive ALOCROSS® or the reference treatment, VISMED® (ratio 1:1) in an investigator-masked fashion
Protocol Amendment History
7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2020-12-22; most recent amendment 2025-05-16.
Status change: Recruiting → Active, Not Recruiting2025-05-16
Status change: Not Yet Recruiting → Recruiting2021-05-18